Home › NDC Lookup › RxCUI directory › RxCUI 859824

Fluphenazine decanoate 25 MG/ML Injectable Solution — RxCUI 859824

RxNorm drug concept · Semantic clinical drug
RxCUI 859824 Semantic clinical drug · SCD ● Current RxNorm concept 10 FDA products 10 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI859824
Official nameFluphenazine decanoate 25 MG/ML Injectable Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped10
Package NDCs mapped10
Reported Medicaid activity (SDUD)42,316 prescriptions · 46 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Fluphenazine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Fluphenazine is an antipsychotic medication used to manage psychotic disorders — most commonly schizophrenia. It's available as tablets, an oral liquid, and injections. The long-ac...
  • Fluphenazine Decanoate Injection is chemically designed to release slowly after a single shot, so one injection can keep working for up to four weeks or even longer. The regular ta...
  • How is the long-acting injection different from the tablets or regular shot?
  • The most common side effects involve movement — things like muscle stiffness, a restless, fidgety feeling, or tremors. These can often be managed by adjusting your dose or adding a...
📖 Read our full Fluphenazine guide →

🕸️ Concept Web — How Fluphenazine decanoate 25 MG/ML Injectable Solut... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Fluphenazine decanoate 25 MG/ML Injectable Solution RxCUI 859824

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Fluphenazine 4496
    • Fluphenazine decanoate 25190
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Fluphenazine Injectable Solution 372237
    • Fluphenazine decanoate Injectable Solution 2649323
    • Fluphenazine Injectable Product 1161441
    • Fluphenazine decanoate Injectable Product 2662122
    • Injectable Solution 316949
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Fluphenazine decanoate 25 MG/ML 859823

Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Fluphenazine decanoate 25 MG/ML SCDC · 859823
  • Fluphenazine Injectable Solution SCDF · 372237
  • Fluphenazine decanoate Injectable Solution SCDFP · 2649323
  • Fluphenazine Injectable Product SCDG · 1161441
  • Fluphenazine decanoate Injectable Product SCDGP · 2662122

📦 FDA Products & Package NDCs

10 products · 10 package NDCs
10 package NDCs map to RxCUI 859824 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00143-9529-01 1 VIAL, MULTI-DOSE in 1 BOX (0143-9529-01) / 5 mL in 1 VIAL... Fluphenazine Decanoate Hikma Pharmaceuticals USA Inc. 1996-08-30
25021-0838-05 1 VIAL in 1 CARTON (25021-838-05) / 5 mL in 1 VIAL Fluphenazine Decanoate Sagent Pharmaceuticals 2023-08-01
42023-0129-01 1 VIAL in 1 CARTON (42023-129-01) / 5 mL in 1 VIAL Fluphenazine Decanoate Endo USA, Inc. 2014-07-09
42023-0129-89 1 VIAL in 1 CARTON (42023-129-89) / 5 mL in 1 VIAL Fluphenazine Decanoate Endo USA, Inc. 2018-06-26
55150-0267-05 1 VIAL, MULTI-DOSE in 1 CARTON (55150-267-05) / 5 mL in 1 V... FLUPHENAZINE DECANOATE Eugia US LLC 2017-10-17
63323-0272-05 1 VIAL, MULTI-DOSE in 1 CARTON (63323-272-05) / 5 mL in 1 V... Fluphenazine Decanoate Fresenius Kabi USA, LLC 2010-12-15
67457-0359-59 1 VIAL, MULTI-DOSE in 1 CARTON (67457-359-59) / 5 mL in 1 V... Fluphenazine Decanoate Mylan Institutional LLC 2018-09-28
68083-0476-01 1 VIAL, MULTI-DOSE in 1 CARTON (68083-476-01) / 5 mL in 1 V... fluphenazine decanoate Gland Pharma Limited 2023-03-30
72162-2635-02 1 VIAL, MULTI-DOSE in 1 CARTON (72162-2635-2) / 5 mL in 1 V... Fluphenazine Decanoate Bryant Ranch Prepack 2026-05-06
72205-0100-01 1 VIAL, MULTI-DOSE in 1 CARTON (72205-100-01) / 5 mL in 1 V... Fluphenazine Decanoate Novadoz Pharmaceuticals LLC 2023-11-23
Observed labelers: Endo USA, Inc. (2) · Bryant Ranch Prepack (1) · Eugia US LLC (1) · Fresenius Kabi USA, LLC (1) · Gland Pharma Limited (1) · Hikma Pharmaceuticals USA Inc. (1) · +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J2680 Fluphenazine decanoate 25 mg 8 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.